logo
Select company
Select metric
$ 1.46MNet Cash Flow - Financing
VS
Market
43
Sector
62
Industry
72
History
70
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

TTNP

Company Name

TITAN PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TITAN PHARMACEUTICALS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TTNP - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 1.46M
3/31/2025$ -81K
12/31/2024$ -62K
9/30/2024$ 406K
6/30/2024$ 10M
3/31/2024$ 10M
12/31/2023$ 10M
9/30/2023$ 9.59M
6/30/2023$ 0
3/31/2023$ 3K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TITAN PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 20.1M.
  • Over the past 5 years, TITAN PHARMACEUTICALS INC's average CF - Financing has been $ 7.94M.
  • The median CF - Financing for TITAN PHARMACEUTICALS INC during this period was $ 6.91M
  • TITAN PHARMACEUTICALS INC reached its highest CF - Financing over the past 5 years at $ 20.1M.
  • The lowest CF - Financing recorded by TITAN PHARMACEUTICALS INC in the same timeframe $ -81K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

TTNP - Net Cash Flow - Financing, Last 5 years

$ -81K

Minimum

Mar 31, 2025

$ 20.1M

Maximum

Sep 30, 2020

$ 7.94M

Average

$ 6.91M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M